FDA Inspection 1096607 — Keystone Rx LLC

Keystone Rx LLC — FEI 3015119302

The FDA completed an inspection of Keystone Rx LLC on July 12, 2019 in Bensalem, PA. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). 1 citation was issued during this inspection. Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
July 12, 2019
Fiscal Year
2019
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Bensalem, PA (United States)

Citations

IDCFRDescription
18936FDCA 501(a)(2)(A)Non-microbial contamination, production area